These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 4762633)

  • 41. Heterogeneity of N-and O-methyltransferases.
    Axelrod J; Vesell ES
    Mol Pharmacol; 1970 Jan; 6(1):78-84. PubMed ID: 5527525
    [No Abstract]   [Full Text] [Related]  

  • 42. Structure-activity correlation for substrates of phenylethanolamine N-methyltransferase (PNMT).
    Fuller RW; Marsh MM
    J Med Chem; 1972 Oct; 15(10):1068-9. PubMed ID: 4672195
    [No Abstract]   [Full Text] [Related]  

  • 43. Assay of phenylethanolamine N-methyltransferase activity using high-performance liquid chromatography with ultraviolet absorbance detection.
    Beaudouin C; Haurat G; Fraisse L; Souppe J; Renaud B
    J Chromatogr; 1993 Mar; 613(1):51-8. PubMed ID: 8458902
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Activation of brain phenylethanolamine-N-methyltransferase by triton-X-100: time related differences in the enzyme activation.
    Chaudhuri S; Parvez H; Parvez S
    Biochem Biophys Res Commun; 1980 May; 94(2):522-8. PubMed ID: 7396915
    [No Abstract]   [Full Text] [Related]  

  • 45. Inhibitors of phenylethanolamine N-methyltransferase. 1. Effects of 2-cycloocytyl-2-hydroxyethylamine on rat brain and adrenal catecholamine content and blood pressure.
    Liang NY; Tessel RE; Grunewald GL; Borchardt RT
    J Pharmacol Exp Ther; 1982 Nov; 223(2):375-81. PubMed ID: 7131292
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Methylmethionine (vitamin U) metabolism in mammals].
    Snegireva LV; Skorobogatova EP; Areshkina LIa
    Prikl Biokhim Mikrobiol; 1973; 9(2):179-85. PubMed ID: 4771031
    [No Abstract]   [Full Text] [Related]  

  • 47. Conformational preference for the binding of biaryl substrates and inhibitors to the active site of phenylethanolamine N-methyltransferase.
    Grunewald GL; Carter AE; Sall DJ; Monn JA
    J Med Chem; 1988 Jan; 31(1):60-5. PubMed ID: 3336033
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Inhibition of phenylethanolamine N-methyltransferase by benzylamines. 1. Structure-activity relationships.
    Fuller RW; Molloy BB; Day WA; Roush BW; Marsh MM
    J Med Chem; 1973 Feb; 16(2):101-6. PubMed ID: 4734201
    [No Abstract]   [Full Text] [Related]  

  • 49. Norepinephrine N-methyltransferase inhibition by benzamidines, phenylacetamidines, benzylguanidines, and phenylethylguanidines.
    Fuller RW; Roush BW; Snoddy HD; Day WA; Molloy BB
    J Med Chem; 1975 Mar; 18(3):304-7. PubMed ID: 1133822
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Catecholamines: strain differences in biosynthetic enzyme activity in mice.
    Ciaranello RD; Barchas R; Kessler S; Barchas JD
    Life Sci I; 1972 Jun; 11(12):565-72. PubMed ID: 4144315
    [No Abstract]   [Full Text] [Related]  

  • 51. Inhibitors of phenylethanolamine-N-methyltransferase. 2. Comparison of nonaromatic analogs of phenylethanolamines, 7,8-dichloro-1,2,3,4-tetrahydroisoquinoline (SKF-64139) and 2,3-dichloro-alpha-methylbenzylamine: effects on rat brain and adrenal catecholamine content and blood pressure.
    Liang NY; Tessel RE; Grunewald GL; Borchardt RT
    J Pharmacol Exp Ther; 1982 Nov; 223(2):382-7. PubMed ID: 7131293
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Properties of 8,9-dichloro-2,3,4,5-tetrahydro-1H-2-benzazepine, an inhibitor of norepinephrine N-methyltransferase.
    Fuller RW; Hemrick-Luecke S; Toomey RE; Horng JS; Ruffolo RR; Molloy BB
    Biochem Pharmacol; 1981 Jun; 30(11):1345-52. PubMed ID: 6268095
    [No Abstract]   [Full Text] [Related]  

  • 53. Genetically controlled alterations in the rate of degradation of phenylethanolamine N-methyltransferase.
    Ciaranello RD; Axelrod J
    J Biol Chem; 1973 Aug; 248(16):5616-23. PubMed ID: 4723903
    [No Abstract]   [Full Text] [Related]  

  • 54. Properties of norepinephrine N-methyltransferase from pigeon brain.
    Fuller RW; Hemrick SK
    Pharmacol Biochem Behav; 1979 Nov; 11(5):563-6. PubMed ID: 531079
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Effect of substance P on dopamine-beta-hydroxylase and phenethanolamine-N-methyltransferase in the adrenal glands of rats].
    Piesche L; Oehme P; Hilse H; Hecht K
    Pharmazie; 1982 Aug; 37(8):591-3. PubMed ID: 6183680
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Synthesis and biochemical evaluation of 3-fluoromethyl-1,2,3, 4-tetrahydroisoquinolines as selective inhibitors of phenylethanolamine N-methyltransferase versus the alpha(2)-adrenoceptor.
    Grunewald GL; Caldwell TM; Li Q; Slavica M; Criscione KR; Borchardt RT; Wang W
    J Med Chem; 1999 Sep; 42(18):3588-601. PubMed ID: 10479290
    [TBL] [Abstract][Full Text] [Related]  

  • 57. 3,7-Disubstituted-1,2,3,4-tetrahydroisoquinolines display remarkable potency and selectivity as inhibitors of phenylethanolamine N-methyltransferase versus the alpha2-adrenoceptor.
    Grunewald GL; Dahanukar VH; Teoh B; Criscione KR
    J Med Chem; 1999 Jun; 42(11):1982-90. PubMed ID: 10354406
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Conformational preferences of dopamine analogues for inhibition of norepinephrine N-methyltransferase. Conformationally defined adrenergic agents.
    Grunewald GL; Pleiss MA; Rafferty MF
    Life Sci; 1982 Sep; 31(10):993-1000. PubMed ID: 7132559
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Identification of epinephrine and phenylethanolamine N-methyltransferase activity in rat retina.
    Cohen J; Hadjiconstantinou M
    Fed Proc; 1984 Sep; 43(12):2725-8. PubMed ID: 6468670
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Inhibition of PNMT activity in the adrenal glands and brain stem of rats.
    Lew JY; Miyamoto T; Goldstein M
    Biochem Pharmacol; 1976 Jun; 25(12):1432-4. PubMed ID: 820352
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.